C[C@H]1CC[C@H]2C(=O)N3[C@@H](CC[C@H](C)[C@H]3c3ccc(Br)cc3)C(=O)N2[C@@H]1c1ccc(Br)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?